Veritas and UAB PLACENTA awarded the KAUNAS CLINIC NIPT TENDER￼ April 4, 2022 by elizarios Leave a Comment Placenta JSC and Veritas Int. LSMU Kaunas Clinic NIPT contract award Non-Invasive Prenatal Test Tender has been successfully awarded to Placenta JSC and Veritas Int. Placenta JSC, the tissue bank and genetic diagnostic company based in Vilnius, Lithuania and Veritas Intercontinental, The Genome Company, molecular diagnostics company, announce that LSMU Kaunas Clinic, one of the largest public clinics in Lithuania and the Baltic region, has confirmed that Placenta JSC and Veritas Intercontinental have been successfully awarded its “Non Invasive Prenatal Tests” tender. Over the next 2 years, Placenta JSC and Veritas Int will provide the Kaunas clinic its non-invasive prenatal tests for trisomies 21, 18, 13 and sexual aneuploidies analysis. The service uses the most advanced technology based on Illumina VeriSeq™NIPT Solution v2. The tender has been awarded to PLACENTA JSC and VERITAS Int. over 6 international molecular diagnostics laboratories. This important opportunity will allow PLACENTA JSC to grow its commercial activity in the Baltic region and for Veritas to further expand its European activities. PLACENTA JSC also offers other Veritas maternal-fetal medicine services including myNewBorn – Neonatal Whole Exome sequencing – and Prenatal WES – Prenatal whole Exome Sequencing. Javier de Echevarria, CEO of Veritas Int. commented:“We are delighted with the successful tender award and this is once again a new step to certify and show the quality of our Veritas accredited lab for preventive and diagnostic genetic testing services.” Ainis Zoruba, CEO of UAB Placenta commented: “We are proud to be representatives of Veritas Int. – one of the leading genetic testing companies in Europe. Thanks to our cooperation, we are able to provide expectant mothers in Lithuania the highest quality genetic testing services at a very affordable price, as well as to expand the understanding of modern genetics and its possibilities and purpose for our patients.” About Veritas Veritas Intercontinental was founded in 2018 to lead the expansion of the Veritas genetic brand and services in Europe, South America, Japan, the Middle East. In 2020, Veritas Intercontinental opened its first laboratory in Europe. With this further expansion, the company now offers a comprehensive product portfolio, which includes the myGenome® service, exome-based genetic testing for cardiovascular and oncologist diseases and genetic testing services for maternal-foetal medicine. Veritas mission is to transform genetic data into useful information for clinical treatments aimed at improving the quality and duration of life with a team of experts in DNA interpretation. About Placenta PLACENTA JSC is a genetic testing company, an official representative of “Veritas Intercontinental” and several other trusted international partners in Lithuania, active since 2013 and based in Vilnius – Santaros Valley – Centre for Innovative Medicine – with the largest hospitals in whole Lithuania. Specialized in promoting advanced genetic testing including NIPT (non-invasive prenatal tests), genetic diseases screening for Newborns, Cancer Risk screening tests and whole genome sequencing-based tests. “Placenta” is also a Lithuanian licenced stem cell bank and official representative of “FamiCord Suisse” stem cell bank – the leader of stem cell banking in Europe. Stem cell storage is provided in combination with adjacent genetic testing services, supplying the Lithuanian patients with unique combination of advanced perinatal services for innovative medicine. “Placenta” is formed by multidisciplinary team comprised of qualified experts and has offices and rooms designated for scientific and medical purposes.